Contribution of the raw material to the aluminum contamination in parenterals

被引:35
作者
Bohrer, D [1 ]
do Nascimento, PC
Binotto, R
Becker, E
Pomblum, S
机构
[1] Univ Fed Santa Maria, Dept Quim, BR-97111970 Santa Maria, RS, Brazil
[2] Univ Fed Santa Maria, Dept Anal Clin & Toxicol, BR-97119900 Santa Maria, RS, Brazil
关键词
D O I
10.1177/0148607102026006382
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 [营养与食品卫生学];
摘要
Background: The extent of aluminum contamination in parenteral nutrition solutions was measured in 35 different commercial products, including amino,acids, electrolytes, glucose, lipids, vitamins trace elements, and albumin. The extent of aluminum contamination in substances used as raw material for preparation of parenterals was also measured. Chemicals from different manufacturers and of different quality grades were analyzed individually. Methods: The measurements were done by atomic absorption spectrometry. Results: The results showed that the same product might have different aluminum content depending on the manufacturer, either for commercial formulations or substances. The highest contaminated chemicals included cystine, NaOH, vitamin C, biotin, gluconate, and Fe and Cr salts. The lowest contaminated chemicals included lipids, apolar amino acids, glucose, HCl, acetic acid, KCl, NaCl, and heparin. Among commercial products, the major contamination rates appeared in calcium gluconate, followed by trace elements, some vitamins, bicarbonate, phosphates salts, and heparin. Conclusions: Comparing the aluminum in commercial products and substances, it can be concluded that the contamination may occur in parenterals because aluminum is present naturally in the chemicals. However, when the composition and concentration of the parenteral solution are considered, the contamination of calcium gluconate, trace elements, some vitamins, phosphates, bicarbonate, and heparin cannot be related only to the raw substances. The aluminum level present in these commercial formulations is too high to come only from the substances; therefore, it is possible that one of the steps of the manufacturing procedure is responsible for elevating the contamination of these products.
引用
收藏
页码:382 / 388
页数:7
相关论文
共 24 条
[1]
ALUMINUM TOXICITY IN PATIENTS WITH CHRONIC-RENAL-FAILURE [J].
ALFREY, AC .
THERAPEUTIC DRUG MONITORING, 1993, 15 (06) :593-597
[2]
[Anonymous], 1998, NIST CRITICALLY SELE
[3]
Aluminum in enteral nutrition formulas and parenteral solutions [J].
Baydar, T ;
Aydin, A ;
Duru, S ;
Isimer, A ;
Sahin, G .
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 1997, 35 (03) :277-281
[4]
SELECTED ULTRATRACE ELEMENTS IN TOTAL PARENTERAL-NUTRITION SOLUTIONS [J].
BERNER, YN ;
SHULER, TR ;
NIELSEN, FH ;
FLOMBAUM, C ;
FARKOUH, SA ;
SHIKE, M .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1989, 50 (05) :1079-1083
[5]
Aluminum neurotoxicity in preterm infants receiving intravenous-feeding solutions [J].
Bishop, NJ ;
Morley, R ;
Chir, B ;
Day, JP ;
Lucas, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (22) :1557-1561
[6]
On-line separation and spectrophotometric determination of low levels of aluminum in high-salt content samples: application to analysis of hemodialysis fluids [J].
Bohrer, D ;
Gioda, A ;
Binotto, R ;
do Nascimento, PC .
ANALYTICA CHIMICA ACTA, 1998, 362 (2-3) :163-169
[7]
COWAN JA, 1993, INORGANIC BIOCH INTR, P8
[8]
Driscoll WR, 1997, NEW ENGL J MED, V337, P1090
[9]
ONLINE ALUMINUM PRECONCENTRATION ON CHELATING RESIN AND ITS FIA SPECTROFLUOROMETRIC DETERMINATION IN FOODS AND DIALYSIS CONCENTRATES [J].
FERNANDEZ, P ;
CONDE, CP ;
GUTIERREZ, A ;
CAMARA, C .
TALANTA, 1991, 38 (12) :1387-1392
[10]
Aluminum exposure and metabolism [J].
Greger, JL ;
Sutherland, JE .
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 1997, 34 (05) :439-474